Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 72 Show results per page	View Search Criteria \| Help With Results

Last Modified: 6/1/1995


1.		Phase III Randomized Study of Chemotherapy with ChlVPP (CLB/VBL/PRDL/PCB) Alternating with PABlOE (PRDL/DOX/BLEO/VCR/VP-16) vs PABlOE Alone for Hodgkin's Disease (Summary Last Modified 06/95)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 69								CRC-TU-HO3001 EU-93029

Last Modified: 5/1/1998


2.		Phase III Randomized Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) vs Fludarabine (FAMP) for Pretreated B-Cell Chronic Lymphocytic Leukemia (Summary Last Modified 05/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 79								EORTC-06942

Last Modified: 5/21/2007 First Published: 9/1/1998


3.		Phase III Randomized Study of a Four-Drug Anthracycline-Based Regimen or a Seven-Drug Hybrid or Eight-Drug Alternating Regimen in Patients With Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Not specified								MRC-UKLG-LY09 EU-98020, NCT00003421

Last Modified: 5/31/2007 First Published: 1/1/1999


4.		Phase III Randomized Study of Observation Versus Chlorambucil After Anti-Helicobacter Therapy in Patients With Low Grade (Stage I) Gastric Lymphoma (Summary Last Modified 12/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 and over								BNLI-LY03 EU-98040, NCT00003617

Last Modified: 5/31/2007 First Published: 12/1/1998


5.		Phase III Randomized Study of Chlorambucil Plus Dexamethasone With or Without Idarubicin Followed by Randomized Low Dose Interferon Alfa Versus Standard Dose Interferon Alfa Versus No Further Therapy in Patients with Stage II-IV Low Grade Non-Hodgkin's Lymphoma (Summary Last Modified 09/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 70								SNLG-NHL-VIII EU-98034, NCT00003639

Last Modified: 1/4/2008 First Published: 2/1/2000


6.		Phase III Randomized Study of Chlorambucil Alone Versus Fludarabine With or Without Cyclophosphamide in Patients With Newly Diagnosed Chronic Lymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Not specified				Other				LRF-CLL4 LRG-MRC-LEUK-CLL4, EU-99030, MRC-LEUK-CLL4, NCT00004218, EUDRACT-58585610, ISRCTN58585610

Last Modified: 1/4/2008 First Published: 9/1/2000


7.		Phase III Randomized Study of Chlorambucil, Mitoxantrone, and Dexamethasone Versus Fludarabine, Mitoxantrone, and Dexamethasone in Patients With Newly Diagnosed Stage III or IV Follicular Non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 70				Other				BNLI-MCD/FMD EU-20035, NCT00006250

Last Modified: 6/10/2004 First Published: 6/1/2001


8.		Phase III Randomized Study of Chlorambucil in Patients With B-Cell Chronic Lymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 to 75				Other				EORTC-06992-CLL-3 NCT00017108

Last Modified: 11/10/2006 First Published: 1/1/2002


9.		Phase III Randomized Study of Chlorambucil Versus Involved-Field Radiotherapy in Patients With Previously Untreated Stage III or IV Follicular Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over				Other				CKVO-2001-01 HOVON-47NHL, EU-20131, HOVON-CKTO-2001-01, EORTC-20013, NCT00028691

Last Modified: 7/16/2007


10.		Phase III Study of Surgery and Chemotherapy with L-PAM or 5-FU/MTX/VCR/CTX/PRED for Breast Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7436 SWOG-7436

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute